Published June 2005
| Version v1
Journal article
Progress of treatment of primary cutaneous B-cell lymphoma
Creators
- 1. Affiliated Hospital, Academy of Military Medical Sciences, Beijing (China)
Description
Primary cutaneous B-cell lymphoma (PCBCL) arises from the skin and always localizes on the skin. Because of good prognosis the therapeutic program of PCBCL is conservative. The fundamental management in recent years such as radiotherapy, polychemotherapy, immunotherapy and combination of these treatments is elaborated. (authors)
Additional details
Publishing Information
- Journal Title
- Bulletin of the Academy of Military Medical Sciences
- Journal Volume
- 29
- Journal Issue
- 3
- Journal Page Range
- p. 299-300
- ISSN
- 1000-5501
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 39093940
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHEMOTHERAPY; COMBINED THERAPY; DRUGS; IMMUNOTHERAPY; LYMPHOCYTES; LYMPHOMAS; RADIOTHERAPY; SKIN; SURGERY
- Descriptors DEC
- ANIMAL CELLS; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY; BODY FLUIDS; CONNECTIVE TISSUE CELLS; DISEASES; IMMUNE SYSTEM DISEASES; LEUKOCYTES; MATERIALS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; SOMATIC CELLS; THERAPY
Optional Information
- Notes
- 4 tabs., 4 refs.